Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × INDUSTRY × Neomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 249 Paclitaxel 172 Carboplatin 164 Gemcitabine 138 Cisplatin 120 Docetaxel 117 Cyclophosphamide 117 Nivolumab 109 Bevacizumab 102 Injections 91 Dexamethasone 80 fludarabine 79 atezolizumab 77 Cetuximab 76 Pemetrexed 73 Fluorouracil 68 venetoclax 65 Irinotecan 62 Rituximab 60 Capecitabine 59 Azacitidine 58 130-nm albumin-bound paclitaxel 54 Leucovorin 50 Lenalidomide 50 Ipilimumab 49 Fulvestrant 49 Oxaliplatin 48 Trastuzumab 46 durvalumab 45 Erlotinib Hydrochloride 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02001909 2015-08-13

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Bayer

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡